About
Peptides, Recombinant Proteins
Areas of Focus
Categories
Biologics & BiopharmaceuticalGene Therapy, RNA & Peptide TherapyTaiwan
Clinical Trials (5)
View allTotal Trials
5
As Lead Sponsor
5
As Collaborator
0
Total Enrollment
1,228
By Phase
PHASE2: 3PHASE3: 1PHASE2/PHASE3: 1
By Status
COMPLETED: 3NOT_YET_RECRUITING: 1RECRUITING: 1
Clinical Trials Pipeline5 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT07078955Lead Sponsor
A Dose Regimen Study of BRM421 Ophthalmic Solution in Patients With Dry Eye Disease
PHASE2Not yet recruiting
99 participants
Started: Dec 31, 2025 · Completed: Mar 31, 2027
NCT05927428Lead Sponsor
Assessment of the Initial Efficacy and Safety of BRM424 Ophthalmic Solutions in Patients With Neurotrophic Keratitis
PHASE2Recruiting
12 participants
Started: Jul 31, 2024 · Completed: Nov 30, 2025
NCT05695781Lead Sponsor
Assessment of the Safety and Efficacy of BRM421 Ophthalmic Solutions in Dry Eye Subjects.
PHASE3Completed
740 participants
Started: Feb 27, 2023 · Completed: Mar 30, 2024
NCT04343287Lead Sponsor
Safety and Efficacy of BRM421 for Dry Eye Syndrome Treatment
PHASE2/PHASE3Completed
220 participants
Started: Jan 15, 2020 · Completed: Jun 23, 2020
NCT03066219Lead Sponsor
Safety and Efficacy of BRM421 for Dry Eye Syndrome
PHASE2Completed
157 participants
Started: Feb 7, 2017 · Completed: Jun 28, 2017
Locations (1)
Headquarters
Taipei, Taiwan
Map
Loading map...